Virological assessment of hospitalized patients with COVID-2019

2020/04/01 by Roman Wölfel, Victor M. Corman, Wolfgang Guggemos +17 · 44 citations
Medicine · #COVID-19 Clinical Research Studies #Long-Term Effects of COVID-19 #SARS-CoV-2 and COVID-19 Research

paper · pdf · doi:10.1038/s41586-020-2196-x

crossref issued 2020/04/01 · crossref published 2020/04/01 · crossref published-online 2020/04/01 · openalex publication_date 2020/04/01 · crossref created 2020/04/01 · crossref published-print 2020/05/28 · crossref deposited 2023/05/20 · openalex created_date 2025/10/10 · crossref indexed 2026/07/29 · openalex updated_date 2026/07/30

Citations

• Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
• A Novel Coronavirus from Patients with Pneumonia in China, 2019
• Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
• First Case of 2019 Novel Coronavirus in the United States
• Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany
• SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients
• The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
• SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Cited by

• CRISPR-based diagnostics
• Tracking SARS-CoV-2 variants of concern in wastewater: an assessment of nine computational tools using simulated genomic data
• Post-viral effects of COVID-19 in the olfactory system and their implications
• Evidence of a Sjögren’s disease–like phenotype following COVID-19 in mice and humans
• Public Health Interventions Guided by Houston’s Wastewater Surveillance Program During the COVID-19 Pandemic
• A realistic agent-based simulation model for COVID-19 based on a traffic simulation and mobile phone data
• Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
• Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
• Enhancement strategies for transdermal drug delivery systems: current trends and applications
• Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
• Engineering nasally delivered IgM antibodies for respiratory viral infections
• Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization
• Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19
• Coronavirus biology and replication: implications for SARS-CoV-2
• DNA methylation changes during acute COVID-19 are associated with long-term transcriptional dysregulation in patients’ airway epithelial cells
• Temporal dynamics in viral shedding and transmissibility of COVID-19
• Characteristics of SARS-CoV-2 and COVID-19
• The ratio between SARS-CoV-2 RNA viral load and culturable viral titre differs depending on the stage of infection: a case study of household transmission in an adult male
• Транзитные системы и их роль в развитии транспорта
• Daily longitudinal sampling of SARS-CoV-2 infection reveals substantial heterogeneity in infectiousness
• Tracking and tracing in the UK: a dynamic causal modelling study
• Estimating epidemiologic dynamics from cross-sectional viral load distributions
• Airborne Transmission of SARS-CoV-2: The Contrast between Indoors and Outdoors
• A multistate assessment of population normalization factors for wastewater-based epidemiology of COVID-19
• Post-COVID exercise intolerance is associated with capillary alterations and immune dysregulations in skeletal muscles
• Pathological sequelae of long-haul COVID
• Ordinary differential equation models of SARS-CoV-2 replication dynamics and antiviral drug efficacies
• Extrapulmonary manifestations of COVID-19
• SARS-CoV-2 (COVID-19) by the numbers
• La deuda externa latinoamericana: un enfoque político
• Semiparametric Bayesian Inference for the Transmission Dynamics of COVID-19 with a State-Space Model
• Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19
• Studying the course of Covid-19 by a recursive delay approach
• Effect of diagnostic testing on the isolation rate in a compartmental\n model with asymptomatic groups
• VIBES: A Multi-Scale Modeling Approach Integrating Within-Host and Between-Hosts Dynamics in Epidemics
• Mathematical Modeling of Business Reopening when Facing SARS-CoV-2 Pandemic: Protection, Cost and Risk
• The signal is not flushed away: Inferring the effective reproduction number from wastewater data in small populations
• On the utility of cloth facemasks for controlling ejecta during respiratory events
• Laboratory tests for the detection of SARS-CoV-2 infection: basic principles and examples
• Could the Spike Protein Derived from mRNA Vaccines Negatively Impact Beneficial Bacteria in the Gut?
• Community Transmission of SARS-CoV-2 by Surfaces: Risks and Risk Reduction Strategies
• Chopping the tail: How preventing superspreading can help to maintain COVID-19 control
• Rapid Emergence and Evolution of SARS-CoV-2 Intrahost Variants among COVID-19 Patients with Prolonged Infections, Singapore
• COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection
• Evaluation of the SARS-CoV-2-IgG response in outpatients by five commercial immunoassays
• Dexamethasone in Hospitalized Patients with Covid-19
• Dexamethasone in Hospitalized Patients with Covid-19.